The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity

Pharmacology, Biochemistry, and Behavior
B R Russell, R Laverty

Abstract

The glycine site-specific N-methyl-D-aspartate (NMDA) antagonist 5-nitro-6,7-dichloro-2,3-quinoxalinedione (ACEA 1021, 4x30 mg/kg, i.p.) given 30 min before dexfenfluramine (4x15 mg/kg, i.p., every 2 h) was unable to prevent dexfenfluramine-induced depletion of 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) content, and 5-HT transporter (5-HTT) density. Another glycine site-specific NMDA antagonist, R(+)-3-aminohydroxypyrrolidin-2-one [(R)-HA 966] (2x30 mg/kg, ip), given 30 min before dexfenfluramine (2x10 mg/kg, ip, 2 hourly) was also unable to prevent regional depletion of 5-HT, 5-HIAA, and 5-HTT density. However, ACEA 1021 (4x30 mg/kg, i.p.) given 30 min before (S)-3,4-methylenedioxymethamphetamine (MDMA, 4x10 mg/kg, 2 hourly, ip) attenuated the regional depletion of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), 5-HT, 5-HIAA content, and 5-HTT density. ACEA 1021 combined with (S)-MDMA also prevented (S)-MDMA-induced hyperthermia without causing hypothermia or preventing an (S)-MDMA-induced increase in locomotor activity.

References

Jan 1, 1977·Annual Review of Pharmacology and Toxicology·B Cox
Apr 7, 1992·European Journal of Pharmacology·C W Callaway, M A Geyer
Jul 1, 1992·Pharmacology, Biochemistry, and Behavior·S C DilsaverJ A Peck
Feb 1, 1991·Pharmacology, Biochemistry, and Behavior·C J GordonD B Miller
Jan 1, 1990·Annals of the New York Academy of Sciences·C J Schmidt, J H Kehne
May 1, 1990·Pharmacology, Biochemistry, and Behavior·M P Johnson, D E Nichols
Apr 1, 1989·Journal of Pharmacological Methods·J G ClementB Brockway
Feb 1, 1987·Pharmacology, Biochemistry, and Behavior·R A GlennonM Yousif
Jul 1, 1987·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·C H FrithR Doblin
Aug 2, 1988·European Journal of Pharmacology·B J LoganY B Yee
Mar 1, 1986·Pharmacology, Biochemistry, and Behavior·P Even, S Nicolaidis
Oct 1, 1986·Journal of Medicinal Chemistry·D E NicholsA T Shulgin
Sep 15, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·S Yehuda, R J Wurtman
Mar 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D S WarnerE Weber
Oct 5, 1996·Lancet·E WebbF Kamali
Jan 10, 1998·European Journal of Pharmacology·R R MatsumotoA G Kanthasamy
Jun 23, 1998·Lancet·J A HenryM Forsling
Nov 5, 1998·Pharmacology, Biochemistry, and Behavior·M Shankaran, G A Gudelsky
Jan 6, 2000·The British Journal of Psychiatry : the Journal of Mental Science·D M SempleE C Johnstone

❮ Previous
Next ❯

Citations

Dec 13, 2005·Pharmacology, Biochemistry, and Behavior·Tatiana BondarevaRichard A Glennon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.